Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vandenberghe

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Haematologica|April 12, 2012
The different faces of Janus kinase inhibitionPeter Vandenberghe
Haematologica|December 10, 2009
New flow cytometry in hematologic malignanciesJan Cools, Peter Vandenberghe
Haematologica|September 2, 2016
Circulating cell-free DNA in hematological malignanciesLieselot Buedts, Peter Vandenberghe
Pediatric Reports|November 5, 2011
Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDSPeter Vandenberghe, Karolien Beel
Haematologica|October 2, 2009
G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasiaKarolien Beel, Peter Vandenberghe
Journal of Immunological Methods|February 26, 2004
A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral bloodLing Ma, Werner Scheers, Peter Vandenberghe
Leukemia Research|May 22, 2009
Reduction of BCR-ABL1 mutant clones after discontinuation of TKI therapyKarolien Beel, Ann Janssens, Gregor Verhoef, et al.
The Open Rheumatology Journal|December 1, 2012
Targeted Therapy with Rituximab in Felty's Syndrome: A Case ReportLine Heylen, Daan Dierickx, Peter Vandenberghe, et al.
Cancer Genetics|October 4, 2011
FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemiaNatalie Put, Dries Deeren, Lucienne Michaux, et al.
Annals of Hematology|March 23, 2004
A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritisHadewijch De Samblanx, Gregor Verhoef, Pierre Zachée, et al.
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Haematologica|April 12, 2012
The different faces of Janus kinase inhibitionPeter Vandenberghe
Haematologica|December 10, 2009
New flow cytometry in hematologic malignanciesJan Cools, Peter Vandenberghe
Haematologica|September 2, 2016
Circulating cell-free DNA in hematological malignanciesLieselot Buedts, Peter Vandenberghe
Pediatric Reports|November 5, 2011
Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDSPeter Vandenberghe, Karolien Beel
Haematologica|October 2, 2009
G-CSF receptor (CSF3R) mutations in X-linked neutropenia evolving to acute myeloid leukemia or myelodysplasiaKarolien Beel, Peter Vandenberghe
Journal of Immunological Methods|February 26, 2004
A flow cytometric method for determination of absolute counts of myeloid precursor dendritic cells in peripheral bloodLing Ma, Werner Scheers, Peter Vandenberghe
Leukemia Research|May 22, 2009
Reduction of BCR-ABL1 mutant clones after discontinuation of TKI therapyKarolien Beel, Ann Janssens, Gregor Verhoef, et al.
The Open Rheumatology Journal|December 1, 2012
Targeted Therapy with Rituximab in Felty's Syndrome: A Case ReportLine Heylen, Daan Dierickx, Peter Vandenberghe, et al.
Cancer Genetics|October 4, 2011
FOXP1 and PAX5 are rare but recurrent translocations partners in acute lymphoblastic leukemiaNatalie Put, Dries Deeren, Lucienne Michaux, et al.
Annals of Hematology|March 23, 2004
A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritisHadewijch De Samblanx, Gregor Verhoef, Pierre Zachée, et al.
Pageof 19